Company intelligence / Profile preview

Henan Lihua Pharmaceutical

Ownership: Private
Employees: ~500
Development stage: Commercial

Overview

Henan Lihua Pharmaceutical is a leading Chinese manufacturer of corticosteroid active pharmaceutical ingredients (APIs) and intermediates. The company produces over 50 varieties of steroids including prednisolone, prednisone, cortisone, betamethasone and their derivatives. Its products comply with major pharmacopeia standards and are exported to nearly 60 countries worldwide. The company has received GMP certification from the Chinese SFDA and CEP certificates from EDQM for several APIs. It has also passed US FDA inspections but received a warning letter in 2018 regarding cGMP compliance.

Therapeutic areas: EndocrinologyImmunologyDermatology
Modalities: Small molecule
Industry: Contract Manufacturing Organization

Partnerships

Pfizer (US)Aceto (Germany)Sanofi (France)

Beyond the preview

Go deeper on Henan Lihua Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Henan Lihua Pharmaceutical.

Explore the full profile